Voltammetric sensor based on Co3O4/SnO2 nanopowders for determination of diltiazem in tablets and biological fluids

被引：31

作者：

Attaran A.M. ^{[1
]}

Abdol-Manafi S. ^{[1
]}

Javanbakht M. ^{[2
]}

Enhessari M. ^{[3
]}

机构：

[1] Department of Chemistry, Payame Noor University, Delijan

[2] Department of Chemistry, Amirkabir University of Technology, Tehran

[3] Department of Chemistry, Naragh Branch, Islamic Azad University, Naragh

来源：

Journal of Nanostructure in Chemistry | 2016年 / 6卷 / 2期

关键词：

Anodic stripping voltammetry; Biological fluids; Cobalt oxide; Diltiazem; Nanocatalyst;

D O I：

10.1007/s40097-015-0186-6

中图分类号：

学科分类号：

摘要：

In this work, an anodic stripping voltammetry for nanomolar determination of diltiazem with a chemically modified carbon paste electrode (CMCPE) containing Co3O4/SnO2 nanopowders was studied. The accumulation potential and time were selected at, −0.2 V and 190 s, respectively. The electroanalytical performance of the CMCPE was evaluated regarding the carbon paste composition, the solution pH, the time and potential accumulation, and the potential interferences. The novel electrode showed linear response to diltiazem concentration range of 50–650 nM with a lowest detection limit value of 15 nM. The precisions for six consecutive determinations of 350 and 550 nM diltiazem were 3.2 and 2.5 %, respectively. It was demonstrated that the proposed method was free from most interference. Finally, the method was effectively applied to the determination of diltiazem in pharmaceutical tablets and biological samples. © 2016, The Author(s).

引用

页码：121 / 128

页数：7

共 35 条

[1]

Feld G., Singh B.N., Diltiazem-pharmacological properties and therapeutic uses, Hosp. Formul., 20, (1985)

[2]

Hermann P., Morselli P.L., Pharmacokinetics of diltiazem and other calcium entry blockers, Acta Pharmacol. Toxicol., 57, pp. 10-20, (1985)

[3]

Kolle E.U., Ochs H.R., Vollmer K.O., Pharmacokinetic model of diltiazem, Arzneim.-Forsch., 33, pp. 972-977, (1983)

[4]

Rovei V., Gomeni R., Mitchard M., Larribaud J., Blatrix C., Thebault J.J., Morselli P.L., Pharmacokinetics and metabolism of diltiazem in man, Acta Cardiol., 35, pp. 35-45, (1980)

[5]

Bianchetti G., Regazzi M., Rondanelli R., Ascalone V., Morselli P.L., Bioavailability of diltiazem as a function of the administered dose, Biopharm. Drug Dispos., 12, pp. 391-401, (1991)

[6]

Suleiman M.S., Abdulhameed M.E., Najib N.M., Muti H.Y., Effect of ultraviolet radiation on the stability of diltiazem, Int. J. Pharm., 50, pp. 71-73, (1989)

[7]

Laeer S., Scholz H., Uebeler P., Neumann J., Zimmermann N.J., Quantitation of diltiazem in human cardiac tissue using high-performance liquid chromatography, Chromatogr. Sci., 35, pp. 93-96, (1997)

[8]

Meehan E., Kelly J.G., High-performance liquid chromatographic assay for diltiazem in small-volume blood specimens and application to pharmacokinetic studies in rats, J. Chromatogr., 729, pp. 297-300, (1996)

[9]

Morris R.G., Saccoia N.C., Jones T.E., Modified liquid chromatographic assay for diltiazem and metabolites in human plasma, Liq. Chromatogr. J. Relat. Technol., 19, pp. 2385-2394, (1996)

[10]

Shi X.J., Zong M.K., Wang H.T., Zhang J.H., Studies on the chemical components of essential oils of Elsholtzia patrini Garcke, Yaowu Fenxi Zazhi, 15, 23, pp. 20-22, (1995)

← 1 2 3 4 →